Feedback / Questions
deuterium pirfenidone (LYT-100) - PureTech
https://www.businesswire.com/news/home/20220613005869/en/PureTech-Reports-Results-from-Phase-2-Study-of-LYT-100-COV-in-Post-Acute-%E2%80%9CLong%E2%80%9D-COVID-with-Respiratory-Complications
Jun 14, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next